Biotricity Inc. (OTCQB: BTCY) is a medical technology company aiming to change the healthcare industry by developing remote monitoring solutions. By using its innovative new technologies, the company not only help physicians better monitor their patients, but also help empower individuals to better manage their lifestyle. The company believe that their monitoring devices are leading the next healthcare evaluation.
Biotricity, founded in 2010, created two innovative monitoring solutions, Bioflux and Biolife. Bioflux is an ECG monitoring system that enables physicians to diagnose Cardiovascular Disease (CVD) or Coronary Heart Disease (CHD). This solution is only available by a prescription. While Biolife is a care solution designed for consumers, individuals wear the devices to track heart-rhythm, respiration, calories, temperature, physical activity and other key assessments to monitor their health.
Biotricity’s Chief Executive Officer and founder Waqaas Al-Siddiq said, “Virtual healthcare will combine human and digital experience by converting as much of the in-person visit into a remote/virtual one. Future systems will solve the need for providing clinical data.”
Biotricity's stock is trading on the OTC Venture Marketplace (OTC QB) under the ticker, “BTCY”. The shares rose as much as 135 percent at its highest of $3.2 a share, up from $1.36 a share in early July this year.